Skip to content

Vestal Point Capital, LP: CBIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Vestal Point Capital, LP on CBIO, newest first. How the timeline and the estimate are built.

Vestal Point Capital, LP held 3,000,000 CBIO shares at 2026-09-30 per its 13F-HR filed 2026-11-16.

no 13D/G or Form 3/4/5 step is dated after the latest 13F period 2026-09-30

  1. event date2026-09-30
    13G/A 3,000,000 shares
    Share basis changed not comparable

    8.1% of the class. Different basis (group aggregate from 13G/A).

    13G/A 0000902664-26-004580 filed by Vestal Point Capital, LP
    Accepted , ingested

    A 13D/G states the aggregate of its reporting persons, which may include entities that do not file a 13F.

  2. period ended2026-09-30
    13F 3,000,000 shares
    Change vs previous 13F +1,370,000 shares

    1.13% of the 13F portfolio, value $43,770,000.

    13F-HR 0001974915-26-000008 filed by Vestal Point Capital, LP
    Accepted , ingested

  3. period ended2026-06-30
    13F 1,630,000 shares
    Change vs previous 13F +130,000 shares

    0.69% of the 13F portfolio, value $29,340,000.

    13F-HR 0001974915-26-000005 filed by Vestal Point Capital, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2026-03-31
    13F 1,500,000 shares
    Change vs previous 13F 0 shares

    0.77% of the 13F portfolio, value $27,555,000.

    13F-HR 0001974915-26-000004 filed by Vestal Point Capital, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-12-31
    13F 1,500,000 shares
    Change vs previous 13F not available

    0.65% of the 13F portfolio, value $17,790,000.

    13F-HR 0001974915-26-000002 filed by Vestal Point Capital, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).